National Institute on Drug Abuse; Notice of Closed Meetings

[Federal Register Volume 64, Number 22 (Wednesday, February 3, 1999)]
[Notices]
[Page 5306]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-2565]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel Treatment.
    Date: March 5, 1999.
    Time: 9:00 AM to 5:00 PM.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 
Bethesda, MD 20814.
    Contact Person: Susan L. Coyle, PhD., Chief, Clinical, 
Epidemiological and Applied Sciences Review Branch, Office of 
Extramural Program Review, National Institute on Drug Abuse, 
National Institutes of Health, DHHS, 5600 Fishers Lane, Room 10-42, 
Rockville, MD 20857, (301) 443-2620.
    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel Medication Development Centers.
    Date: March 10-11, 1999.
    Time: 9:00 AM to 5:00 PM.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 
Bethesda, MD 20814.
    Contact Person: Khursheed Asghar, PhD., Chief, Basic Sciences 
Review Branch, Office of Extraumural Program Review, National 
Institute on Drug Abuse, National Institutes of Health, DHHS, 
Rockville, MD 20857, (301) 443-2620.

(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug 
Abuse Scientist Development Award for Clinicians, Scientist 
Development Awards, and Research Scientist Awards; 93.278, Drug 
Abuse National Research Service Awards for Research Training; 
93.279, Drug Abuse Research Programs, National Institutes of Health, 
HHS)

    Dated: January 29, 1999.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 99-2565 Filed 2-2-99; 8:45 am]
BILLING CODE 4140-01-M